Sri Mahasai Fine Chemicals Hyderabad Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 17-07-2024
- Paid Up Capital ₹ 1.17 Cr
as on 17-07-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.52 Cr
as on 17-07-2024
- Revenue -27.37%
(FY 2023)
- Profit 7.72%
(FY 2023)
- Ebitda 8.82%
(FY 2023)
- Net Worth 16.68%
(FY 2023)
- Total Assets 20.26%
(FY 2023)
About Sri Mahasai Fine Chemicals Hyderabad
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.17 Cr.
The company currently has active open charges totaling ₹5.52 Cr.
Rudra Balla and Pilli Rao serve as directors at the Company.
- CIN/LLPIN
U24304TG2017PTC117844
- Company No.
117844
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Nalgonda, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sri Mahasai Fine Chemicals Hyderabad?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rudra Balla  | Managing Director | 21-Jun-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pilli Rao | Director | 11-May-2022 | Current |
Financial Performance of Sri Mahasai Fine Chemicals Hyderabad.
Sri Mahasai Fine Chemicals Hyderabad Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.37% decrease. The company also saw a slight improvement in profitability, with a 7.72% increase in profit. The company's net worth Soared by an impressive increase of 16.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Mahasai Fine Chemicals Hyderabad?
In 2023, Sri Mahasai Fine Chemicals Hyderabad had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The South Indian Bank Limited Creation Date: 19 Jun 2023 | ₹0.20 M | Open |
The South Indian Bank Limited Creation Date: 28 May 2018 | ₹5.50 Cr | Open |
How Many Employees Work at Sri Mahasai Fine Chemicals Hyderabad?
Unlock and access historical data on people associated with Sri Mahasai Fine Chemicals Hyderabad, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Mahasai Fine Chemicals Hyderabad, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Mahasai Fine Chemicals Hyderabad's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
